It generated a genetically diverse set of subtypes that are clinically relevant and span from fusion-driven uniform and immune cold sarcomas to more pleiomorphic, genetically unstable tumors, with a tendency towards increased immune infiltrates, dominated by TP53 inactivation. Here, TP53 is linked to sarcoma.